Adult height after cranial irradiation for optic pathway tumors: Relationship with neurofibromatosis

Journal of Pediatrics

Volumn 142, Issue 6, 2003, Pages 699-703

  Huguenin, Marion ^a   Trivin, Christine ^a   Zerah, Michel ^a   Doz, François ^a   Brugieres, Laurence ^a   Brauner, Raja ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; GONADORELIN DERIVATIVE; GROWTH HORMONE; THYROTROPIN;

ADOLESCENT; ADULT; ARTICLE; BODY HEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; DELAYED PUBERTY; DISEASE ASSOCIATION; FEMALE; HORMONE DETERMINATION; HUMAN; MALE; NEUROFIBROMATOSIS; OPTIC PATHWAY TUMOR; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; RADIATION DOSE; SKULL IRRADIATION; TUMOR; TUMOR DIAGNOSIS;

EID: 0038132259     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2003.234     Document Type: Article

References (26)

1. Brauner R, Malandry F, Rappaport R, Zucker JM, Kalifa C, Pierre-Kahn A, et al. Growth and endocrine disorders in optic glioma. Eur J Pediatr 1990;149:825-8.
2. Szudek J, Birch P, Friedman JM, National Neurofibromatosis Foundation International Database Participants. Growth in North American white children with neurofibromatosis 1 (NF1). J Med Genet 2000;37:933-8.
3. NIH Consensus Development Conference. Neurofibromatosis: conference statement. Arch Neurol 1988;45:575-8.
4. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976;51:170-9.
5. Sempe M, Pedron G, Roy-Pernot MP. Auxologie, méthode et séquences. Paris (France): Théraplix; 1979.
6. Rolland-Cachera MF, Cole TJ, Sempé M, Tichet J, Rossignol C, Charraud A. Body mass index variations: centiles from birth to 87 years. Eur J Clin Nutr 1991;45:13-21.
7. Tanner JM, Goldstein H, Whitehouse RH. Standards for children's height at ages 2-9 years allowing for height of parents. Arch Dis Child 1970;47:755-62.
8. Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. Stanford (CA): Stanford University Press; 1959.
9. Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with Greulich Pyle hand standards. J Pediatr 1952;50:432-41.
10. Bussières L, Souberbielle JC, Pinto G, Adan L, Noel M, Brauner R. The use of insulin-like growth factor I reference values for the diagnosis of growth hormone deficiency in prepubertal children. Clin Endocrinol 2000;52:735-9.
11. Oerter KE, Uriarte MM, Rose SR, Barnes KM, Cutler GB Jr. Gonadotropin secretory dynamics during puberty in normal girls and boys. J Clin Endocrinol Metab 1990;71:1251-8.
12. Collett-Solberg PF, Sernyak H, Satin-Smith M, Katz LL, Sutton L, Molloy P, et al. Endocrine outcome in long-term survivors of low-grade hypothalamic/chiasmatic glioma. Clin Endocrinol 1997;47:79-85.
13. Chemaitilly W, Trivin C, Adan L, Gall V, Sainte-Rose C, Brauner R. Central precocious puberty: clinical and laboratory features. Clin Endocrinol 2001;54:289-94.
14. Chalumeau M, Chemaitilly W, Trivin C, Adan L, Bréart G, Brauner R. Central precocious puberty in girls: an evidence-based diagnosis tree to predict central nervous system abnormalities. Pediatrics 2002;109:61-7.
15. Cnossen MH, Stare EN, Cooiman LCMG, Simonsz HJ, Stroink H, Oranje AP, et al. Endocrinologic disorders and optic pathway gliomas in children with neurofibromatosis type 1. Pediatrics 1997;100:667-70.
16. Virdis R, Sigorini M, Laiolo A, Lorenzetti E, Street ME, Villani AR, et al. Neurofibromatosis type 1 and precocious puberty. J Pediatr Endocrinol Metab 2000;13(suppl 1):841-4.
17. Habiby R, Silverman B, Listernick R, Charrow J. Precocious puberty in children with neurofibromatosis type 1. J Pediatr 1995;126:364-7.
18. Listernick R, Charrow J, Greenwald M, Mets M. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr 1994;125:63-6.
19. Listernick R, Charrow J, Gutmann DH. Intracranial gliomas in neurofibromatosis type 1. Am J Med Genet 1999;89:38-44.
20. Vassilopoulou-Sellin R, Klein MJ, Slopis JK. Growth hormone deficiency in children with neurofibromatosis type 1 without suprasellar lesions. Pediatr Neurol 2000;22:355-8.
21. Howel SJ, Wilton P, Lindberg A, Shalet SM. Growth hormone replacement and the risk of malignancy in children with neurofibromatosis. J Pediatr 1998;133:201-5.
22. Carmi D, Shohat M, Metzker A, Dickerman Z. Growth, puberty, and endocrine functions in patients with sporadic or familial neurofibromatosis type 1: a longitudinal study. Pediatrics 1999;103:1257-62.
23. Clementi M, Milani S, Mammi I, Boni S, Monciotti C, Tenconi R. Neurofibromatosis type 1 growth charts. Am J Med Genet 1999;87:317-23.
24. Adan L, Chemaitilly W, Trivin C, Brauner R. Factors predicting adult height in girls with idiopathic central precocious puberty: implications for treatment. Clin Endocrinol 2002;56:297-302.
25. Cappelli C, Grill J, Raquin M, Pierre-Kahn A, Lellouch-Tubiana A, Terrier-Lacombe MJ, et al. Long term follow up of 69 patients treated for optic pathway turnouts before the chemotherapy era. Arch Dis Child 1998;79:334-8.
26. Bataini JP, Delanian S, Ponvert D. Chiasmal gliomas: results of irradiation management in 57 patients and review of literature. Int J Radiat Oncol Biol Phys 1991;21:615-23.